Stock AREV AREV LIFE SCIENCES GLOBAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AREV Life Sciences Global Corp.

Equities

AREV

CA04019J1093

Food Processing

Market Closed - Canadian Securities Exchange
Other stock markets
 12:06:40 2023-07-11 pm EDT 		5-day change 1st Jan Change
0.09 CAD -10.00% Intraday chart for AREV Life Sciences Global Corp. -.--% -.--%
2023 AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 12.63 12.2 1.986 5.477 8.337 2.05
Enterprise Value (EV) 1 11.86 12.62 2.53 5.916 8.254 2.079
P/E ratio -8.53 x -1.13 x -0.59 x -4.47 x -6.13 x -1.35 x
Yield - - - - - -
Capitalization / Revenue - - 10,201,751 x 28,739,727 x 32,692,917 x 41,739,010 x
EV / Revenue - - 12,993,430 x 31,040,162 x 32,369,123 x 42,324,191 x
EV / EBITDA -15.9 x -7.67 x -0.86 x -11.8 x -5.34 x -1.59 x
EV / FCF -40.8 x -13.5 x 9.49 x -9.07 x -13.2 x 103 x
FCF Yield -2.45% -7.39% 10.5% -11% -7.6% 0.97%
Price to Book 14.4 x -53.9 x -3.78 x -9.61 x -89.2 x -2.15 x
Nbr of stocks (in thousands) 3,508 8,131 9,458 17,958 26,892 31,537
Reference price 2 3.600 1.500 0.2100 0.3050 0.3100 0.0650
Announcement Date 4/30/18 4/30/19 6/16/20 5/28/21 5/2/22 11/17/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - 0.1947 0.1906 0.255 0.0491
EBITDA 1 -0.7438 -1.644 -2.955 -0.4998 -1.544 -1.311
EBIT 1 -0.7954 -1.696 -3.021 -0.601 -1.643 -1.389
Operating Margin - - -1,551.76% -315.34% -644.44% -2,827.74%
Earnings before Tax (EBT) 1 -1.02 -8.427 -3.193 -1.049 -0.9903 -1.444
Net income 1 -1.02 -8.427 -3.193 -1.049 -0.9903 -1.444
Net margin - - -1,639.99% -550.37% -388.36% -2,940.37%
EPS 2 -0.4218 -1.332 -0.3565 -0.0683 -0.0506 -0.0480
Free Cash Flow 1 -0.2906 -0.9323 0.2666 -0.6525 -0.6273 0.0202
FCF margin - - 136.93% -342.39% -246% 41.11%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/18 4/30/19 6/16/20 5/28/21 5/2/22 11/17/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 0.42 0.54 0.44 - 0.03
Net Cash position 1 0.77 - - - 0.08 -
Leverage (Debt/EBITDA) - -0.2551 x -0.1839 x -0.8772 x - -0.0219 x
Free Cash Flow 1 -0.29 -0.93 0.27 -0.65 -0.63 0.02
ROE (net income / shareholders' equity) -178% -2,300% 1,080% 180% 270% 276%
ROA (Net income/ Total Assets) -40.5% -96.9% -248% -34.8% -108% -198%
Assets 1 2.516 8.7 1.29 3.011 0.9159 0.728
Book Value Per Share 2 0.2500 -0.0300 -0.0600 -0.0300 -0 -0.0300
Cash Flow per Share 2 0.2800 0 0 0.0100 0.0100 0
Capex 1 0.11 - 0.22 0.31 0.01 0.03
Capex / Sales - - 110.47% 161.7% 4.72% 55.34%
Announcement Date 4/30/18 4/30/19 6/16/20 5/28/21 5/2/22 11/17/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
AREV LIFE SCIENCES GLOBAL CORP. Stock AREV Life Sciences Global Corp.
-.--% 2.09M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+0.34% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.45% 802M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. AREV Stock
  4. Financials AREV Life Sciences Global Corp.